Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-171P is a human pseudogene that is homologous to U7 small nuclear RNA, a molecule essential for 3' end processing of replication-dependent histone pre-mRNAs[6]. While the functional U7 snRNA forms part of the U7 snRNP complex participating in histone mRNA cleavage and processing[1][3][5], pseudogenes like RNU7-171P represent noncoding, nonfunctional genetic elements within the genome. These segments have lost their capacity for expression and function due to accumulated mutations and are generally considered "genomic fossils" or "gene relics"[8]. RNU7-171P does not produce the U7 snRNA nor participates in the biological pathways of its ancestor. Most pseudogenes, including RNU7-171P, have historically been considered transcriptionally inactive "junk DNA," though recent research suggests that some pseudogenes may exhibit regulatory roles; no such function has been ascribed to RNU7-171P specifically[8]. Unlike the bona fide U7 snRNA gene, this pseudogene is neither a drug target nor a biomarker, and it is not implicated in any known diseases.
Not applicable. No mechanisms of drug action are relevant to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 171 pseudogene (RNU7-171P).